GENIL.E — Gen Ilac ve Saglik Urunleri Sanayi Ticaret Share News
0.000.00%
Last trade - 00:00- TRY18.09bn
- TRY23.17bn
- TRY19.18bn
Brief: Gen Ilac Says It Is To Supply 227 Mln Lira Worth Of Drugs For Salutem's Contract With Turkish State Supply Office
Brief: Gen Ilac Says It Obtains Exclusive Rights For Leqembi With Eisai Europe For Distribution In Turkey
Brief: Gen Ilac Says It Signs Distributorship Agreement By 3-Years With France-Based Balt International Sas
Brief: Gen Ilac Q3 Net Profit Up At 215.8 Mln Lira YoY
Brief: Gen Ilac Says Salutem Ecza Deposu Wins Turkish State Supply Office Tender To Supply 261.9 Mln Lira Worth Of Co's Drugs
Brief: Gen Ilac Q2 Net Result Turns To Profit Of 77.8 Mln Lira YoY
Brief: Gen Ilac Says It Signs Distribution Agreement With Santhera Pharmaceuticals, Based In Switzerland
Brief: Gen Ilac Says It Decides To Participate In Capital Increase Carried Out By Subsidiary Gen Pharma Caucasus Manufacturing Operations MMC
Brief: Gen Ilac Says Result Of Phase 1 Clinical Trials Of Sul-238 Indicates That It Is Safe And Well-Tolerated In Healthy Volunteers
RCS - GEN Pharmaceuticals - GEN and Sulfateq BV Announce Positive Phase 1
Brief: Gen Ilac Says It Decides To Increase Share Capital To 4.5 Bln Lira From 300 Mln Lira Via Bonus Issue
Brief: Gen Ilac Says Salutem, Authorized by Gen Ilac, Wins State Supply Office Tenders, Drug Sales Via Salutem To Contribute 116.5 Mln Lira To Total Sales
Brief: Gen Ilac Says It Submits $18 Mln Bank Guarantee Letter For Azerbaijan Facility
Brief: Gen Ilac Says It Is To Make 1.9 Mln USD Capital Payment To RS Research
Brief: Gen Ilac Says It Decides Issue Debt Securities Worth Up To 3.00 Bln Lira To Qualified Domestic Investors
Brief: Gen Ilac Says It Decides To Issue Lease Certificates Worth Up To 2.00 Bln Lira To Domestic Qualified Investors
Brief: Gen Ilac Says It Is To Supply Drugs To State Supply Office Tender Winner Salutem Worth 73.1 Mln Lira
Brief: Gen Ilac Q1 Net Profit Up At 319.8 Mln Lira YoY
Brief: Gen Ilac Says It Signs Distributorship Agreement With Unikeris